BioCardia (BCDA) Withdrawn

Developing regenerative medicine for heart failure based a patient's own bone marrow.

Health Care -

IPO Performance
Latest Trade ()
First Day Return
Return from IPO
 
BioCardia IPO News more
  • .
IPO Data
IPO File Date 06/16/2015
Offer Price
Price Range $12.00 - $14.00
Offer Shares (mm) 3.8
Deal Size ($mm) $50
 
IPO Data
IPO Date
Offer Price
Price Range $12.00 - $14.00
Offer Shares (mm) 3.8
Deal Size ($mm) $$50
 
Underwriters
more
Business Overview
Developing regenerative medicine for heart failure based a patient's own bone marrow.
Developing regenerative medicine for heart failure based a patient's own bone marrow.
more
Company Data
Headquarters San Carlos, CA
Founded 2002
Employees 30
Website www.biocardia.com
 

Performance vs. IPO Index (IPOUSA)